Sabin Vaccine Institute Elects New Trustees Bringing Expertise to Support Program Growth

WASHINGTON, D.C. – The Sabin Vaccine Institute (Sabin) announces the appointment of three new members to its Board of Trustees. Joining the Board are Drs. Elizabeth Fox, Saad Omer and Jacqueline Shea, well-respected leaders whose range of skills and experience promise to advance Sabin’s aim to ensure all people, everywhere get the vaccines they need.

GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute

LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) today announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus.

Sabin Vaccine Institute and The Aspen Institute Release Report Calling for Bold, New, and Coordinated Commitments to Making Universal Influenza Vaccines a Reality

WASHINGTON, D.C. – A new report released today by the Sabin-Aspen Vaccine Science & Policy Group, a joint initiative of the Sabin Vaccine Institute and the Aspen Institute, calls for an urgent, coordinated effort to amplify and focus resources on the long-sought, but overdue achievement of a universal influenza vaccine (UIV).

Dr. Carol Baker Receives 2019 Albert B. Sabin Gold Medal

Washington, D.C. – The Sabin Vaccine Institute (Sabin) today announced it will present its annual Albert B. Sabin Gold Medal to Dr. Carol J. Baker, whose groundbreaking research in Group B Streptococcus (GBS) is accelerating progress toward a much-needed vaccine to prevent a bacterial infection that can cause lifelong illness or death in newborns.

Multidisciplinary Experts Leverage Global Action for Local Impact to Protect Communities at Risk of Typhoid and Related Diseases

HANOI, VIETNAM – Beginning today, the 11th International Conference on Typhoid and Other Invasive Salmonelloses brings together more than 450 researchers, policy makers and advocates who are dedicated to improving the lives of young children and their families suffering from typhoid, paratyphoid and invasive non-typhoidal Salmonella.

Sabin Statement on Senate HELP Committee Hearing on What is Driving Preventable Disease Outbreaks

WASHINGTON, D.C. – Today, the Senate Health, Education, Labor, and Pensions (HELP) Committee conducted a hearing on rising rates of vaccine hesitancy causing preventable disease outbreaks across the country – such as the ongoing outbreaks in Washington, Illinois, and New York.

The Bill & Melinda Gates Foundation and the Sabin Vaccine Institute Partner to Improve Vaccine Access by Strengthening Immunization Programs

WASHINGTON, DC - With the mutual goal of improving access to life-saving vaccines, the Bill & Melinda Gates Foundation recommitted its support to the Sabin Vaccine Institute (Sabin) to relaunch a global network for immunization managers.

Rotavirus Experts Share Latest Research, Call for Increased Vaccine Coverage at Symposium

MINSK, BELARUS – Beginning today, the 13th International Rotavirus Symposium, hosted by the Sabin Vaccine Institute, the U.S. Centers for Diseases Control, PATH, ROTA Council, the Fogarty International Center at the U.S. National Institutes of Health, the Government of the Republic of Belarus, and the Bill & Melinda Gates Foundation, is bringing together scientific experts, policy makers and public health officials to share the latest developments in the fast-moving field of rotavirus prevention.

Pages